​

West Pharmaceutical Services (WST) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

WST Stock Forecast

West Pharmaceutical Services (WST) stock forecast, based on 14 Wall Street analysts, predicts a 12-month average price target of $304.43, with a high of $340.00 and a low of $265.00. This represents a 27.78% increase from the last price of $238.25.

$200 $240 $280 $320 $360 $400 High: $340 Avg: $304.43 Low: $265 Last Closed Price: $238.25

WST Stock Rating

West Pharmaceutical Services stock's rating consensus is Buy, based on 14 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (71.43%), 3 Hold (21.43%), 1 Sell (7.14%), and 0 Strong Sell (0.00%).

Buy
Total 14 0 1 3 10 Strong Sell Sell Hold Buy Strong Buy

WST Price Target Upside V Benchmarks

TypeNameUpside
StockWest Pharmaceutical Services27.78%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks22.38%

Price Target Trends

1M3M12M
# Anlaysts3514
Avg Price Target$306.67$307.00$315.43
Last Closing Price$238.25$238.25$238.25
Upside/Downside28.72%28.86%32.39%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Mar, 262113--16
Feb, 262113--16
Jan, 262113--16
Dec, 252112--15
Nov, 251113--15
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Feb 13, 2026Dan LeonardUBS$340.00$246.6037.88%42.71%
Feb 13, 2026Deutsche Bank$315.00$247.4927.28%32.21%
Feb 13, 2026Luke SergottBarclays$265.00$243.618.78%11.23%
Feb 10, 2026David WindleyJefferies$295.00$249.9718.01%23.82%
Feb 03, 2026Daniel MarkowitzEvercore ISI$320.00$237.8834.52%34.31%
Dec 01, 2025Morgan Stanley$285.00$274.143.96%19.62%
Oct 27, 2025Barclays$325.00$293.6210.69%36.41%
Oct 24, 2025Dan LeonardUBS$355.00$307.2515.54%49.00%
Oct 24, 2025Justin BowersDeutsche Bank$345.00$304.7413.21%44.81%
Oct 23, 2025Daniel MarkowitzEvercore ISI$390.00$309.2826.10%63.69%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Feb 13, 2026UBSBuyBuyhold
Feb 13, 2026Deutsche BankBuyBuyhold
Feb 10, 2026JefferiesBuyBuyhold
Feb 03, 2026Evercore ISIOutperformOutperformhold
Oct 29, 2025Cowen & Co.Buyinitialise
Oct 24, 2025UBSBuyBuyhold
Oct 24, 2025Deutsche BankBuyBuyhold
Oct 23, 2025Evercore ISIOutperformOutperformhold
May 22, 2025CitigroupBuyBuyhold
Jan 08, 2025CitigroupBuyinitialise

Financial Forecast

EPS Forecast

$6 $7 $8 $9 $10 $11 $12 Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$8.90$7.88$7.99$6.75$6.83---
Avg Forecast$8.49$8.17$8.01$6.63$7.45$8.77$9.98$11.10
High Forecast$8.62$8.27$8.10$6.67$7.67$9.11$10.17$11.31
Low Forecast$8.40$8.10$7.96$6.55$7.30$8.29$9.82$10.92
Surprise %4.83%-3.55%-0.25%1.81%-8.32%---

Revenue Forecast

$3B $3B $3B $3B $4B $4B Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$2.83B$2.89B$2.95B$2.89B$3.07B---
Avg Forecast$2.81B$2.84B$2.96B$2.88B$3.04B$3.31B$3.50B$3.71B
High Forecast$2.84B$2.86B$3.00B$2.89B$3.06B$3.31B$3.52B$3.77B
Low Forecast$2.79B$2.82B$2.92B$2.85B$3.03B$3.31B$3.48B$3.67B
Surprise %0.70%1.77%-0.22%0.27%1.14%---

Net Income Forecast

$400M $500M $600M $700M $800M $900M Dec 21 Dec 22 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 21Dec 22Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$661.80M$585.90M$593.40M$492.70M$493.70M---
Avg Forecast$503.69M$609.47M$593.40M$499.60M$563.43M$637.89M$749.00M$835.83M
High Forecast$604.43M$731.37M$712.08M$502.29M$577.28M$685.83M$765.83M$851.78M
Low Forecast$402.95M$487.58M$474.72M$493.31M$549.58M$623.92M$739.61M$822.61M
Surprise %31.39%-3.87%--1.38%-12.38%---

WST Forecast FAQ

Is West Pharmaceutical Services stock a buy?

West Pharmaceutical Services stock has a consensus rating of Buy, based on 14 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 3 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that West Pharmaceutical Services is a favorable investment for most analysts.

What is West Pharmaceutical Services's price target?

West Pharmaceutical Services's price target, set by 14 Wall Street analysts, averages $304.43 over the next 12 months. The price target range spans from $265 at the low end to $340 at the high end, suggesting a potential 27.78% change from the previous closing price of $238.25.

How does West Pharmaceutical Services stock forecast compare to its benchmarks?

West Pharmaceutical Services's stock forecast shows a 27.78% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (22.38%).

What is the breakdown of analyst ratings for West Pharmaceutical Services over the past three months?

  • March 2026: 12.50% Strong Buy, 68.75% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 12.50% Strong Buy, 68.75% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.
  • January 2026: 12.50% Strong Buy, 68.75% Buy, 18.75% Hold, 0% Sell, 0% Strong Sell.

What is West Pharmaceutical Services’s EPS forecast?

West Pharmaceutical Services's average annual EPS forecast for its fiscal year ending in December 2026 is $8.77, marking a 28.40% increase from the reported $6.83 in 2025. Estimates for the following years are $9.98 in 2027, and $11.1 in 2028.

What is West Pharmaceutical Services’s revenue forecast?

West Pharmaceutical Services's average annual revenue forecast for its fiscal year ending in December 2026 is $3.31B, reflecting a 7.67% increase from the reported $3.07B in 2025. The forecast for 2027 is $3.5B, and $3.71B for 2028.

What is West Pharmaceutical Services’s net income forecast?

West Pharmaceutical Services's net income forecast for the fiscal year ending in December 2026 stands at $637.89M, representing an 29.21% increase from the reported $493.7M in 2025. Projections indicate $749M in 2027, and $835.83M in 2028.